Acuna SA, et al. – Analysts aimed at determining cancer recurrence after solid organ transplantation. As compared to historic reports used to establish recommendations for listing patients with pre–transplant malignancy (PTM), the risk of cancer recurrence in recipients with PTM was considerably lower. There appeared limited evidence to support minimum cancer remission times before transplantation.